Clinical Trials Browser

Disease Progression × Bevacizumab × Clear all

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT00393094 2012-07-13

Bevacizumab and Irinotecan to Treat Brain Tumors

Phase 2 Terminated

31 enrolled 12 charts

Brain Neoplasms, Glioma, Disease Progression